PCQRF yields 2500.00% · JNJ yields 2.14%● Live data
📍 PCQRF pulled ahead of the other in Year 1
Combined, PCQRF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PCQRF + JNJ for your $10,000?
Petrolympic Ltd. engages in the acquisition, exploration, and development of gold, petroleum, and natural gas properties in the United States and Canada. It holds a 100% interest covering an area of 55,951 hectares in the St. Lawrence Lowlands and Gaspe Peninsula; 30% interest of the 216,933 hectares with Ressources et Energie Squatex in the Utica Fairway and the underlying Trenton-Black River carbonates; and 12% interest of the total land package 8,000 hectares through an Agreement with Canbriam Energy. The company also holds 100% interest in the Mitis and the Matapedia properties covering an area of 41,014 hectares; and 30% interest in approximately 431,160 hectares through a joint venture with Squatex. In addition, it holds interest in the Vauquelin gold property that consists of 31 contiguous claims covering an area of 1,784 hectares located in the east of the Val d´Or mining camp, Quebec; and the Evangelic Lake Gold property that consists of 24 mining claims covering 600 hectares located in southwest of Espanola, Ontario. Further, the company has an agreement to acquire 100% interest in the Belcourt Gold property comprising 125 claims covering an area of 5,479 hectares situated near Val d'Or, Quebec; and the Rayon d'Or gold property that consists of two contiguous claims covering an area of 285.9 acres located in the east of the Val d´Or mining camp, Quebec. Petrolympic Ltd. is headquartered in Toronto, Canada.
Full PCQRF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.